-
Je něco špatně v tomto záznamu ?
Passive Tumor Targeting of Polymer Therapeutics: In Vivo Imaging of Both the Polymer Carrier and the Enzymatically Cleavable Drug Model
R. Pola, AK. Heinrich, T. Mueller, L. Kostka, K. Mäder, M. Pechar, T. Etrych,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
27654467
DOI
10.1002/mabi.201600273
Knihovny.cz E-zdroje
- MeSH
- akrylamidy * chemie farmakokinetika farmakologie MeSH
- fluorescenční barviva * chemie farmakokinetika farmakologie MeSH
- kolorektální nádory * farmakoterapie metabolismus patologie MeSH
- lidé MeSH
- myši nahé MeSH
- myši MeSH
- nosiče léků * chemie farmakokinetika farmakologie MeSH
- xenogenní modely - testy protinádorové aktivity MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The enzymatic release of a model drug from a polymer carrier inside a tumor using multispectral optical imaging in vivo in nude mice bearing colorectal carcinomas HT-29 and DLD-1 is demonstrated. Much higher release rate in vivo from a linear (30 kDa) (N-2-hydroxypropyl)methacrylamide-based polymer compared with a high molecular weight branched (170 kDa) polymer conjugate is observed, probably due to steric hindrance of the cleavable spacer of the latter polymer to proteolytic enzymes. There is no significant difference in the relative biodistribution of the two polymers, but the branched polymer circulates much longer. Both polymers are labeled with two different fluorophores. Dyomics-676 as a drug model is attached to the polymer via an enzymatically cleavable Gly-Phe-Leu-Gly spacer; Dyomics 782 is bound to the same polymer via a nondegradable amide bond, enabling the tracking of the polymer carrier after i.v. application to mice.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18017029
- 003
- CZ-PrNML
- 005
- 20180521091300.0
- 007
- ta
- 008
- 180515s2016 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/mabi.201600273 $2 doi
- 035 __
- $a (PubMed)27654467
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Pola, Robert $u Department of Biomedical Polymers, Institute of Macromolecular Chemistry AS CR, Heyrovsky Sq. 2, 162 06, Prague, Czech Republic.
- 245 10
- $a Passive Tumor Targeting of Polymer Therapeutics: In Vivo Imaging of Both the Polymer Carrier and the Enzymatically Cleavable Drug Model / $c R. Pola, AK. Heinrich, T. Mueller, L. Kostka, K. Mäder, M. Pechar, T. Etrych,
- 520 9_
- $a The enzymatic release of a model drug from a polymer carrier inside a tumor using multispectral optical imaging in vivo in nude mice bearing colorectal carcinomas HT-29 and DLD-1 is demonstrated. Much higher release rate in vivo from a linear (30 kDa) (N-2-hydroxypropyl)methacrylamide-based polymer compared with a high molecular weight branched (170 kDa) polymer conjugate is observed, probably due to steric hindrance of the cleavable spacer of the latter polymer to proteolytic enzymes. There is no significant difference in the relative biodistribution of the two polymers, but the branched polymer circulates much longer. Both polymers are labeled with two different fluorophores. Dyomics-676 as a drug model is attached to the polymer via an enzymatically cleavable Gly-Phe-Leu-Gly spacer; Dyomics 782 is bound to the same polymer via a nondegradable amide bond, enabling the tracking of the polymer carrier after i.v. application to mice.
- 650 12
- $a akrylamidy $x chemie $x farmakokinetika $x farmakologie $7 D000178
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a kolorektální nádory $x farmakoterapie $x metabolismus $x patologie $7 D015179
- 650 12
- $a nosiče léků $x chemie $x farmakokinetika $x farmakologie $7 D004337
- 650 12
- $a fluorescenční barviva $x chemie $x farmakokinetika $x farmakologie $7 D005456
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši nahé $7 D008819
- 650 _2
- $a xenogenní modely - testy protinádorové aktivity $7 D023041
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Heinrich, Anne-Kathrin $u Department of Pharmacy, Pharmaceutical Technology, and Biopharmacy, Martin Luther University Halle-Wittenberg, 06120, Halle, Germany.
- 700 1_
- $a Mueller, Thomas $u Department of Internal Medicine IV, Oncology/Hematology, Martin Luther University Halle-Wittenberg, 06120, Halle, Germany.
- 700 1_
- $a Kostka, Libor $u Department of Biomedical Polymers, Institute of Macromolecular Chemistry AS CR, Heyrovsky Sq. 2, 162 06, Prague, Czech Republic.
- 700 1_
- $a Mäder, Karsten $u Department of Pharmacy, Pharmaceutical Technology, and Biopharmacy, Martin Luther University Halle-Wittenberg, 06120, Halle, Germany.
- 700 1_
- $a Pechar, Michal $u Department of Biomedical Polymers, Institute of Macromolecular Chemistry AS CR, Heyrovsky Sq. 2, 162 06, Prague, Czech Republic.
- 700 1_
- $a Etrych, Tomas $u Department of Biomedical Polymers, Institute of Macromolecular Chemistry AS CR, Heyrovsky Sq. 2, 162 06, Prague, Czech Republic.
- 773 0_
- $w MED00006593 $t Macromolecular bioscience $x 1616-5195 $g Roč. 16, č. 11 (2016), s. 1577-1582
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27654467 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180521091442 $b ABA008
- 999 __
- $a ok $b bmc $g 1300653 $s 1013869
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 16 $c 11 $d 1577-1582 $e 20160922 $i 1616-5195 $m Macromolecular bioscience $n Macromol Biosci $x MED00006593
- LZP __
- $a Pubmed-20180515